- Home
- LXEO vs INFU Comparison
LXEO vs INFU Comparison
Compare LXEO & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- INFU
- Stock Information
- Founded
- LXEO 2017
- INFU 2005
- Country
- LXEO United States
- INFU United States
- Employees
- LXEO N/A
- INFU N/A
- Industry
- LXEO
- INFU Medical/Dental Instruments
- Sector
- LXEO
- INFU Health Care
- Exchange
- LXEO Nasdaq
- INFU Nasdaq
- Market Cap
- LXEO 93.9M
- INFU 124.0M
- IPO Year
- LXEO 2023
- INFU N/A
- Fundamental
- Price
- LXEO $4.65
- INFU $5.71
- Analyst Decision
- LXEO Strong Buy
- INFU Strong Buy
- Analyst Count
- LXEO 5
- INFU 1
- Target Price
- LXEO $16.60
- INFU $12.00
- AVG Volume (30 Days)
- LXEO 435.8K
- INFU 103.5K
- Earning Date
- LXEO 08-11-2025
- INFU 08-11-2025
- Dividend Yield
- LXEO N/A
- INFU N/A
- EPS Growth
- LXEO N/A
- INFU 3654.89
- EPS
- LXEO N/A
- INFU 0.15
- Revenue
- LXEO N/A
- INFU $137,582,000.00
- Revenue This Year
- LXEO N/A
- INFU $11.06
- Revenue Next Year
- LXEO N/A
- INFU $7.86
- P/E Ratio
- LXEO N/A
- INFU $39.24
- Revenue Growth
- LXEO N/A
- INFU 7.98
- 52 Week Low
- LXEO $1.45
- INFU $4.61
- 52 Week High
- LXEO $13.63
- INFU $9.97
- Technical
- Relative Strength Index (RSI)
- LXEO 61.04
- INFU 44.86
- Support Level
- LXEO $3.60
- INFU $5.38
- Resistance Level
- LXEO $4.31
- INFU $6.31
- Average True Range (ATR)
- LXEO 0.33
- INFU 0.21
- MACD
- LXEO -0.00
- INFU 0.01
- Stochastic Oscillator
- LXEO 71.95
- INFU 39.29
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.